文献速递血液净化与透析

多层面质量改进干预预防血液透析导管相关血流感染:一项系统综述

Multifaceted Quality Improvement Interventions to Prevent Hemodialysis Catheter-Related Bloodstream Infections: A Systematic Review.
PubMed 文献 · Am J Kidney Dis · 2023-05-12

该系统综述检索了PubMed、EMBASE和CENTRAL至2022年4月23日,纳入21项研究,评估多层面质量改进干预对非ICU血液透析患者导管相关血流感染(HDCRBSI)或通路相关血流感染(ARBSI)的影响。在15项测量HDCRBSI的研究中,2项方法学异质的整群随机试验报告了不一致的干预效果,2项中断时间序列分析报告了有利效果但模式不一致,11项前后对照研究报告有利效果但偏倚风险极高。总体证据质量HDCRBSI为低,ARBSI为极低。

要点

  • 多层面质量改进干预可能预防非ICU的HDCRBSI,但支持证据质量低。
  • 15项测量HDCRBSI的研究中,2项整群随机试验效果不一致。
  • 6项仅测量ARBSI的研究中,1项时间序列分析和1项前后对照研究未发现有利效果。

核心结论

  • 多层面质量改进干预可能预防非ICU的HDCRBSI,但支持证据质量低,需进一步精心设计的研究。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE和CENTRAL从建库至2022年4月23日,纳入随机试验、时间序列分析和前后对照研究,共21项研究。

主要发现

  • 15项测量HDCRBSI的研究中,2项方法学异质的整群随机试验报告不一致的干预效果。
  • 2项中断时间序列分析报告有利干预效果但效应模式不一致。
  • 11项前后对照研究报告有利干预效果但偏倚风险极高。
  • 6项仅测量ARBSI的研究中,1项时间序列分析和1项前后对照研究未发现有利干预效果,4项前后对照研究报告有利效果但偏倚风险极高。
  • 总体证据质量HDCRBSI为低,ARBSI为极低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 使用了9种HDCRBSI定义。
  • 10项研究纳入医院和卫星设施但未报告各类型设施的单独干预效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Central venous catheters (CVCs) are widely used for hemodialysis but are prone to burdensome and costly bloodstream infections. We determined whether multifaceted quality improvement interventions in hemodialysis units can prevent hemodialysis catheter-related bloodstream infections (HDCRBSI). STUDY DESIGN: Systematic review. SETTING & STUDY POPULATIONS: PubMed, EMBASE, and CENTRAL were searched from inception to April 23, 2022, to identify randomized trials, time-series analyses, and before-after studies that examined the effect of multifaceted quality improvement interventions on the incidence of HDCRBSI or access-related bloodstream infections (ARBSI) among people receiving hemodialysis outside of the intensive care unit (ICU). DATA EXTRACTION: Two people independently extracted data and assessed the risk of bias and quality of evidence using validated tools. ANALYTICAL APPROACH: Intervention effects, validity, and characteristics of studies with the same design were compared. Differences between study designs were described. RESULTS: We included 21 studies from 8,824 identified by our search. Among 15 studies that measured HDCRBSI, 2 methodologically heterogenous cluster randomized trials reported discordant intervention effects, 2 interrupted time-series analyses reported favorable interventions with discordant patterns of effect, and 11 before-after studies reported favorable interventions with a very high risk of bias. Among 6 studies that only measured ARBSI, 1 time-series analysis and 1 before-after study did not find a favorable intervention effect, and 4 before-after studies reported a favorable effect with a very high risk of bias. The overall quality of evidence was low for HDCRBSI and very low for ARBSI. LIMITATIONS: Nine definitions of HDCRBSI were used. Ten studies included hospital-based and satellite facilities but did not report separate intervention effects for each type of facility. CONCLUSIONS: Multifaceted quality improvement interventions may prevent HDCRBSI outside the ICU. However, evidence supporting them is of low quality, and further carefully conducted studies are warranted. REGISTRATION: Registered at PROSPERO with registration number CRD42021252290. PLAIN-LANGUAGE SUMMARY: People with kidney failure rely on central venous catheters to facilitate life-sustaining hemodialysis treatments. Unfortunately, hemodialysis catheters are a common source of problematic bloodstream infections. Quality improvement programs have effectively prevented catheter-related infections in intensive care units, but it is unclear whether they can be adapted to patients using hemodialysis catheters in the community. In a systematic review that included 21 studies, we found that most quality improvement programs were reported to be successful. However, the findings were mixed among higher-quality studies, and overall the quality of evidence was low. Ongoing quality improvement programs should be complemented by more high-quality research.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Lazarus B, Bongetti E, Ling J, et al. Multifaceted Quality Improvement Interventions to Prevent Hemodialysis Catheter-Related Bloodstream Infections: A Systematic Review. Am J Kidney Dis. 2023. PMID: 37178814. doi:10.1053/j.ajkd.2023.02.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。